1
TÍTULO: Patient-reported outcomes from the randomized phase III ALEX study of alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer  Full Text
AUTORES: Maurice Perol; Nick Pavlakis; Evgeny Levchenko; Marco Platania; Julio Oliveira; Silvia Novello; Rita Chiari; Teresa Moran; Emmanuel Mitry; Eveline Nueesch; Ting Liu; Bogdana Balas; Krzysztof Konopa; Solange Peters;
PUBLICAÇÃO: 2019, FONTE: LUNG CANCER, VOLUME: 138
INDEXADO EM: WOS
3
TÍTULO: Safety and Resource Utilization by Non-small Cell Lung Cancer Histology. Results from the Randomized Phase III Study of Pemetrexed Plus Cisplatin versus Gemcitabine Plus Cisplatin in Chemonaïve Patients with Advanced Non-small Cell Lung Cancer
AUTORES: Silvia Novello; Francisco Luis Pimentel; Jean-Yves Douillard; Mary OʼBrien; Joachim von Pawel; John Eckardt; Astra M Liepa; Lorinda Simms; Carla Visseren-Grul; Luis Paz-Ares;
PUBLICAÇÃO: 2010, FONTE: Journal of Thoracic Oncology, VOLUME: 5, NÚMERO: 10
INDEXADO EM: CrossRef: 7